ARCHIVES

Studies Question PSA Screening: PLCO Trial Finds No Survival Advantage, European Trial Finds Benefit At High Cost

This article is from The Cancer Letter archive.

Vol. 35 No. 11 | March 20, 2009

Download PDF Visit The Full Archive

Related Articles

Amgen Commits $1.5M To CDC Foundation For Education Program

May 29, 2009

In Brief: Ross Retires From Bristol-Myers, Forms Own Consulting Service; Obey Wins Key Post

April 1, 1994

Approval Granted For New Formulation of Lupron Depot

July 29, 2011

NCS Group Asks DRG Adjustments For Institutions With Peer reviewed Components, 25 Protocol Patients

July 1, 1983

About Need For Cancer Research Funding

February 3, 1995

In Brief: Comprehensive Designation To MN Center; Bernardin Center Wins NCI Planning Grant

October 16, 1998